Author

J. H. Ostrander

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

B. W. Welm· 1 shared C. A. Lange· 1 shared C. Perez Kerkvliet· 1 shared C.-H. Yang· 1 shared E. A. Benner· 1 shared E. Cortes-Sanchez· 1 shared K. M. Hagen· 1 shared K. P. Guillen· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. W. Welm

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivAug 7, 2020

PELP1/SRC-3-dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancer

T. H. Truong, E. A. Benner, K. M. Hagen…·J. H. Ostrander

This study identifies PELP1/SRC-3-dependent regulation of metabolic kinases as a driver of therapy-resistant ER+ breast cancer and shows that targeting PFKFBs can block tumorsphere formation in resistant models.

DOI 10.1038/s41388-021-01871-w

humanproteomics

𝕏 PostBluesky